Nothing Special   »   [go: up one dir, main page]

FI951887A0 - Laastarit haihtuvien, farmaseuttisesti vaikuttavien, kemiallisesti emäksisten aineiden antamiseen ihon läpi, ja menetelmä niiden valmistamiseksi - Google Patents

Laastarit haihtuvien, farmaseuttisesti vaikuttavien, kemiallisesti emäksisten aineiden antamiseen ihon läpi, ja menetelmä niiden valmistamiseksi

Info

Publication number
FI951887A0
FI951887A0 FI951887A FI951887A FI951887A0 FI 951887 A0 FI951887 A0 FI 951887A0 FI 951887 A FI951887 A FI 951887A FI 951887 A FI951887 A FI 951887A FI 951887 A0 FI951887 A0 FI 951887A0
Authority
FI
Finland
Prior art keywords
matrix
volatile
salt
pharmaceutically active
patch
Prior art date
Application number
FI951887A
Other languages
English (en)
Swedish (sv)
Other versions
FI112325B (fi
FI951887A (fi
Inventor
Karin Wolter
Walter Mueller
Guenter Simon
Christa Nalbach
Rainer Hoffmann
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of FI951887A publication Critical patent/FI951887A/fi
Publication of FI951887A0 publication Critical patent/FI951887A0/fi
Application granted granted Critical
Publication of FI112325B publication Critical patent/FI112325B/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI951887A 1992-10-22 1995-04-20 Menetelmä laastarin valmistamiseksi, jolla voidaan ihon läpi antaa haihtuvia, farmaseuttisesti vaikuttavia, kemiallisesti emäksisiä aineosia FI112325B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP92118036 1992-10-22
EP92118036A EP0593807A1 (en) 1992-10-22 1992-10-22 Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
EP9302899 1993-10-20
PCT/EP1993/002899 WO1994008571A2 (de) 1992-10-22 1993-10-20 Pflaster zur transdermalen verabreichung von flüchtigen, pharmazeutisch wirksamen, chemisch basischen inhaltsstoffen und verfahren zu seiner herstellung

Publications (3)

Publication Number Publication Date
FI951887A FI951887A (fi) 1995-04-20
FI951887A0 true FI951887A0 (fi) 1995-04-20
FI112325B FI112325B (fi) 2003-11-28

Family

ID=8210159

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951887A FI112325B (fi) 1992-10-22 1995-04-20 Menetelmä laastarin valmistamiseksi, jolla voidaan ihon läpi antaa haihtuvia, farmaseuttisesti vaikuttavia, kemiallisesti emäksisiä aineosia

Country Status (24)

Country Link
EP (2) EP0593807A1 (fi)
JP (1) JP3731016B2 (fi)
KR (1) KR100261913B1 (fi)
AT (1) ATE165001T1 (fi)
AU (1) AU674902B2 (fi)
CA (1) CA2146645C (fi)
CZ (1) CZ290122B6 (fi)
DE (1) DE59308413D1 (fi)
DK (1) DK0665745T3 (fi)
ES (1) ES2116572T3 (fi)
FI (1) FI112325B (fi)
HR (1) HRP931308A2 (fi)
HU (1) HU221594B (fi)
IL (1) IL107360A (fi)
MY (1) MY109783A (fi)
NO (1) NO311404B1 (fi)
NZ (1) NZ257829A (fi)
PH (1) PH30790A (fi)
PL (1) PL173552B1 (fi)
SI (1) SI9300559A (fi)
SK (1) SK51595A3 (fi)
WO (1) WO1994008571A2 (fi)
YU (1) YU48350B (fi)
ZA (1) ZA937807B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4433191A1 (de) * 1994-09-17 1996-03-21 Lohmann Therapie Syst Lts Selbstklebendes Pflaster zur Abgabe von Wirkstoff an die Umgebung eines Trägers
US6319954B1 (en) 1995-01-13 2001-11-20 Somerset Pharmaceuticals, Inc. S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions
US6299901B1 (en) 1995-01-13 2001-10-09 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6033682A (en) 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
US6348208B1 (en) 1995-01-13 2002-02-19 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6316022B1 (en) 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
JPH11506744A (ja) * 1995-06-07 1999-06-15 ノウブン ファーマシューティカルズ インク. 室温で液体である低分子量薬を含む経皮組成物
WO1997006788A1 (en) * 1995-08-14 1997-02-27 Janssen Pharmaceutica N.V. Transdermal administration of vorozole
DE19533772C1 (de) * 1995-09-12 1998-01-02 Hexal Ag Tacrin/Selegilin-Pflaster
US7150881B2 (en) 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
DE19733981A1 (de) * 1997-08-06 1999-02-11 Lohmann Therapie Syst Lts Transdermales Therapeutisches System (TTS) zur Abgabe von Wirkstoff durch die Haut an einen Organismus und Verfahren zur Applikation auf der Haut
AU9553398A (en) * 1997-11-04 1999-05-24 Clear Sport Ltd Improvements relating to adhesive devices such as strips, tapes, patches and thelike, for application to the human body
DK1063981T3 (da) 1998-03-16 2002-10-14 Somerset Pharmaceuticals Inc Anvendelse af selegilin eller desmethylselegilin til behandling af sår, brandsår og dermatologiske skader
DE19814083C2 (de) * 1998-03-30 2002-02-07 Lohmann Therapie Syst Lts Verfahren zur Herstellung von transdermalen therapeutischen Systemen unter Verwendung von basischen Alkalimetallsalzen zur Umwandlung von Wirkstoffsalzen in die freien Basen
DE19814257A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
DE19826592A1 (de) * 1998-06-15 1999-12-16 Lohmann Therapie Syst Lts Verfahren zur Herstellung eines aus einzelnen Schichten bestehenden Laminats
DE19950066A1 (de) * 1999-10-16 2001-04-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut
EP1441708B1 (en) 2001-11-05 2009-04-08 Krele Pharmaceuticals LLC Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism
GEP20125717B (en) 2007-07-10 2012-12-25 Agile Therapeutics Inc Device for medicine direct dermal delivery
US20100087768A1 (en) 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
AP3030A (en) 2010-04-30 2014-11-30 Teikoku Pharma Usa Inc Propynylaminoindan transdermal compositions
US9119799B2 (en) 2011-03-24 2015-09-01 Teikoku Pharma Usa, Inc. Transdermal compositions comprising an active agent layer and an active agent conversion layer
KR20150059177A (ko) 2012-11-02 2015-05-29 테이코쿠 팔마 유에스에이, 인코포레이티드 프로피닐아미노인단 경피 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds

Also Published As

Publication number Publication date
WO1994008571A3 (de) 1994-05-26
HU9501125D0 (en) 1995-06-28
HUT71684A (en) 1996-01-29
KR100261913B1 (ko) 2000-08-01
AU674902B2 (en) 1997-01-16
NO951523L (no) 1995-04-21
ES2116572T3 (es) 1998-07-16
JP3731016B2 (ja) 2006-01-05
EP0665745A1 (de) 1995-08-09
WO1994008571A2 (de) 1994-04-28
NZ257829A (en) 1996-11-26
HU221594B (hu) 2002-11-28
SK51595A3 (en) 1997-03-05
DK0665745T3 (da) 1999-02-08
HRP931308A2 (en) 1994-12-31
ZA937807B (en) 1994-05-16
AU5462794A (en) 1994-05-09
PL308292A1 (en) 1995-07-24
EP0593807A1 (en) 1994-04-27
EP0665745B1 (de) 1998-04-15
FI112325B (fi) 2003-11-28
IL107360A (en) 1998-06-15
YU67293A (sh) 1996-02-19
YU48350B (sh) 1998-07-10
PL173552B1 (pl) 1998-03-31
NO951523D0 (no) 1995-04-21
JPH08502279A (ja) 1996-03-12
CZ102295A3 (en) 1995-11-15
CA2146645C (en) 2004-06-29
ATE165001T1 (de) 1998-05-15
IL107360A0 (en) 1994-01-25
FI951887A (fi) 1995-04-20
DE59308413D1 (de) 1998-05-20
PH30790A (en) 1997-10-17
NO311404B1 (no) 2001-11-26
CZ290122B6 (cs) 2002-06-12
SI9300559A (en) 1994-06-30
KR950703939A (ko) 1995-11-17
MY109783A (en) 1997-06-30
CA2146645A1 (en) 1994-04-28

Similar Documents

Publication Publication Date Title
FI951887A0 (fi) Laastarit haihtuvien, farmaseuttisesti vaikuttavien, kemiallisesti emäksisten aineiden antamiseen ihon läpi, ja menetelmä niiden valmistamiseksi
US5122383A (en) Sorbitan esters as skin permeation enhancers
CA2153572A1 (en) Transdermal therapeutic system with galanthamine as active ingredient
EP0328806A3 (en) Estradiol transdermal delivery system
US5227169A (en) Sorbitan esters as skin permeation enhancers
KR900015761A (ko) 경피성 단일체 시스템
PT81751B (pt) Processo para a preparacao de adesivos para aplicacao de medicamentos por via transdermica
CA2030178A1 (en) Transdermal therapeutic system comprising as active component buprenorphine
US6531149B1 (en) Estradiol-containing patch for transdermal application of hormones
ES2127384T3 (es) Parche de sustancia activa para la administracion de estradiol por la piel.
US5212199A (en) Sorbitan esters as skin permeation enhancers
FI953532A0 (fi) Nitroglyserolia sisältävä laastari, menetelmä sen valmistamiseksi ja sen käyttö
ES2105334T3 (es) Sistema terapeutico percutaneo para la administracion de fisostigmina en la piel y el procedimiento para su obtencion.
ZA200100721B (en) Estradiol-containing patch for transdermal administration of hormones.

Legal Events

Date Code Title Description
MM Patent lapsed